Pharmacology | Comprehensive Lecture | MRCP(UK) Part 1 | Premium Lecture | Crack Medicine

Поделиться
HTML-код
  • Опубликовано: 11 дек 2024

Комментарии • 6

  • @portiaa1596
    @portiaa1596 4 месяца назад +1

    Very good video but the sound quality is not great

  • @maythanzinsoe8178
    @maythanzinsoe8178 Год назад +1

    Thank you for free videos sir

  • @mohammadnazmul539
    @mohammadnazmul539 Год назад +1

    Thanks a lot sir

  • @VipulSPanditg
    @VipulSPanditg Год назад +1

    Andexanet alfa is the antodote of apixaban in Question 16 !

    • @CrackMedicine
      @CrackMedicine  Год назад

      Thanks for the update Dr!
      As per the NICE guidelines, andexanet alfa for reversing anticoagulation (by apixaban or rivaroxaban) is recommended for routine use only in gastrointestinal bleeding. It is recommended only in research in ICH.
      While, Idarucizumab (Praxbind®) is the Licensed reversal agent for dabigatran.